We aim to develop Cytiva’s innovation pipeline by working and partnering with the best external organizations and innovators available to us.

Partnering with external organizations enables Cytiva to access and develop technologies which in turn allows us to support our customers to discover, diagnose and manufacture new medicines. We recognize the wealth of innovation available within the external scientific community and continue to actively seek value-enhancing opportunities across our areas of interest.

We also have a broad patent portfolio available for licensing that spans many different technologies, reagents and, methods. Please see our out-licensing page for more information.